NAUTILUS: OKI-179 Plus Binimetinib in Patients with Advanced Solid Tumors in the RAS Pathway (Phase 1b) and NRAS-mutated Melanoma (Phase 2)
Clinical trial NCT05340621 · COMPLETED
Trial details
- NCT number
- NCT05340621
- Sponsor
- OnKure, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2025-01-29
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.